跳至主要内容
临床试验/NCT00925223
NCT00925223Unknown不适用

Study of Brain-derived Neurotrophic Factor in Visceral Hyperalgesia in IBS Patients

Shandong University0 个研究点目标入组 30 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
30

研究概览

简要总结

Brain-derived neurotrophic factor (BDNF), originally known to be a member of the nerve growth factor family, has aroused attention as a modulator in visceral hyperalgesia recently. Visceral hypersensitivity is recognized as a clinical hallmark in IBS patients. So in this study, the investigators will focus on the role of BDNF in colonic hyperalgesia in IBS patients.

研究设计

研究类型
Observational
观察模型
Case Control

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with irritable bowel syndrome.

排除标准

  • Patients have similar clinical symptoms as IBS, yet there is morphologic changes in the intestine.

研究者

发起方
Shandong University
申办方类型
Other

相似试验

Brain-derived Neurotrophic Factor Participates in... | 临床试验